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Abstract
Angiogenesis after pulmonary ischemia is initiated by reactive O2 species and is dependent on CXC chemokine growth
factors, and its magnitude is correlated with the number of lavaged macrophages. After complete obstruction of the left
pulmonary artery in mice, the left lung is isolated from the peripheral circulation until 5–7 days later, when a new systemic
vasculature invades the lung parenchyma. Consequently, this model offers a unique opportunity to study the differentiation
and/or proliferation of monocyte-derived cells within the lung. In this study, we questioned whether macrophage
subpopulations were differentially expressed and which subset contributed to growth factor release. We characterized the
change in number of all macrophages (MHCII
int, CD11C+), alveolar macrophages (MHCII
int, CD11C+, CD11B2) and mature
lung macrophages (MHCII
int, CD11C+, CD11B+) in left lungs from mice immediately (0 h) or 24 h after left pulmonary artery
ligation (LPAL). In left lung homogenates, only lung macrophages increased 24 h after LPAL (vs. 0 h; p,0.05). No changes in
proliferation were seen in any subset by PCNA expression (0 h vs. 24 h lungs). When the number of monocytic cells was
reduced with clodronate liposomes, systemic blood flow to the left lung 14 days after LPAL decreased by 42% (p,0.01)
compared to vehicle controls. Furthermore, when alveolar macrophages and lung macrophages were sorted and studied in
vitro, only lung macrophages secreted the chemokine MIP-2a (ELISA). These data suggest that ischemic stress within the
lung contributes to the differentiation of immature monocytes to lung macrophages within the first 24 h after LPAL. Lung
macrophages but not alveolar macrophages increase and secrete the proangiogenic chemokine MIP-2a. Overall, an increase
in the number of lung macrophages appears to be critical for neovascularization in the lung, since clodronate treatment
decreased their number and attenuated functional angiogenesis.
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Introduction
Prolonged organ ischemia is profoundly injurious and results in
a sequelae of cellular changes. In the ventilated lung, pulmonary
ischemia does not result in the loss of cellular oxygenation but
rather the cessation of perfusion-dependent stimuli including a
decreased delivery of glucose/metabolic substrates, decreased
endothelial shear stress, accumulation of blood borne inflamma-
tory cells, and a relative increase in oxygen. This chronic condition
in the lung promotes a series of events that culminate in reversal of
the ischemic state by systemic neovascularization. Pulmonary
ischemia resulting from chronic pulmonary artery obstruction has
been shown to cause proliferation of the systemic circulation
within and surrounding the lung (bronchial arteries and intercostal
arteries) in humans [1,2], sheep [3], pigs [4], dogs [5], and rats [6].
Using a mouse model of total left pulmonary artery ischemia, we
have shown that subsequent neovascularization arises exclusively
from intercostal arteries [7], is initiated by reactive oxygen species
[8], is dependent on early upregulation of CXC chemokine growth
factors [9], and that blockade of CXCR2, the G-protein coupled
receptor through which these predominantly macrophage and
epithelial cell-derived factors operate, results in diminished
angiogenesis [10,11]. Furthermore, our laboratory has shown a
significant positive correlation between the number of monocytes/
macrophages in bronchoalveolar lavage fluid and the magnitude
of neovascularization [12]. Histological sections of the lung after
the onset of ischemia demonstrate an abundance of macrophages
with some showing signs of proliferation and others, markers of
apoptosis [13]. These results are consistent with the hypothesis
that monocytes/macrophages within the lung contribute to sys-
temic neovascularization of the ischemic lung. Furthermore, these
observations contribute to a growing body of literature demon-
strating the importance of macrophage-derived proteins to an-
giogenesis [14].
Macrophages are a heterogeneous group of mononuclear pha-
gocytic cells which display remarkable plasticity and are best
defined by their function within a given tissue. However, ma-
turation state of these cells is typically based on the expression of a
variety of cell-surface markers. Normally, immature monocytes
migrate randomly from blood to various organs and differentiate
into tissue macrophages through the coordinated expression of
numerous genes [15]. After tissue injury or during local infection,
blood monocytes are recruited to a specific organ as inflammatory
macrophages where further differentiation can occur [16,17].
Normally, peripheral blood monocytes circulating through the
pulmonary circulation can become sequestered within pulmonary
capillaries and migrate into the interstitial and alveolar spaces
where they mature into alveolar macrophages. Studies in mice
demonstrated that the generation of alveolar macrophages in-
volves the differentiation of immature blood monocytes into
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the lung parenchyma, proliferative expansion of these cells, and
their subsequent emigration into the alveolar space (CD11B2,
CD11C+; [18]. Given our model of complete pulmonary ischemia
after left pulmonary artery ligation, the fate and activity of trapped
blood monocytes as well as resident macrophages is not clear. Both
reactive oxygen species (ROS) and lung matrix fragments are
known to stimulate macrophages [19]. Our previous work demon-
strates that pulmonary ischemia results in an early increase in
ROS [8] and hyaluronan fragmentation [20]. Since the mouse
lung lacks an intrathoracic bronchial circulation, the ischemic lung
is completely isolated from the peripheral circulation. Inflamma-
tory macrophages that might be recruited cannot access the lung
until a new systemic vascular bed is established 5–7 days after
LPAL [7]. Thus, the model offers the unique opportunity to
examine early monocyte differentiation in an organ without
peripheral influence. In the present study, we sought to better
characterize the phenotype and function of trapped monocytes/
macrophages in the lung during acute pulmonary ischemia. We
hypothesized that monocytes both differentiate and proliferate in
response to sustained pulmonary ischemia and contribute to lung
remodeling through subsequent systemic angiogenesis.
Methods
Animals
The use of mice followed an in vivo protocol approved by the
Johns Hopkins Animal Care and Use Committee (Protocol
number MO10M257). We studied male mice (C57Bl/6, 5–6
weeks old; Charles River Wilmington, MA) as was previously
described [12,21]. Mice were anesthetized (2% isoflurane),
intubated and ventilated (120 breaths/min, 0.2 ml/breath). A left
lateral thoracotomy was performed followed by ligation of the left
pulmonary artery (LPAL). The left lung was harvested either
immediately upon LPAL (0 h LPAL) or the thoracotomy was
closed, the mouse was extubated and allowed to recover for a
specified time. Sham mice were treated similarly to LPAL mice in
all respects except did not undergo LPAL. For lung tissue
acquisition and bronchoalveolar lavage, anesthetized mice were
killed by cervical dislocation at specified times after LPAL.
Bronchoalveolar lavage
Immediately after death, the entire right lung was ligated and
the left lung was washed (360.3 ml of 0.2% BSA/PBS with 2 mM
EDTA, 37uC). Bronchoalveolar lavage fluid was gently aspirated,
the total recovered volume recorded, and total cell count (Bright
Line Hemacytometer; Horsham, PA), and differential cell counts
(Cytospin 4; Shandon, Pittsburgh, PA and Diff-quick staining;
Dade Bering, Newark, DE) were determined where approximately
800 cells/mouse were evaluated. For flow cytometric analysis of
lavaged cells, cells were labeled according to protocols applied for
lung cells.
In vitro monocyte culture and evaluation: Left and right
lungs from naı ¨ve mice were harvested after cervical dislocation.
Lungs were intubated and treated with collagenease (1 mg),
minced and incubated at 37uC, then pushed through a 70 mm
nylon cell strainer (BD Falcon). Erythrocytes were lysed (ACK
buffer) and CD11C+ cells were collected using CD11C microbe-
ads (Miltenyi Biotec, Auburn, CA). Cells (1–2610
5/well/250 ml)
were plated on 96-well dishes (in DMEM supplemented with 10%
FCS and antibiotics:penicillin, streptomycin, gentamicin). Cells
were allowed to adhere (18 h) and were incubated with vehicle or
stimuli in DMEM for 24 h. Stimuli included known macrophage
stimulants H2O2 (100 mM) and low molecular weight hyaluronan
(130 kDa, 250 mg/ml). Concentrations were selected based on
pilot studies and previously published observations [22]. After in-
cubation, supernatant from cultured cells was collected and MIP-
2a was measured by ELISA (R&D Systems, Minneapolis, MN).
Inflammatory cell identification by flow cytometry
Freshly extracted mouse lung tissue was minced, digested
(25 min in collagenase at 37uC), and then pushed and washed
through a 70 mM cell strainer. After lysing erythrocytes (ACK
buffer), cells were washed and the cell pellet was collected. Non-
specific binding sites were blocked (Fc Block; BD Pharmingen, San
Jose, CA), and cells were incubated with monoclonal antibodies
(20 min on ice). Staining reagents for monocytes/macrophages
included: APC-Alexa fluor 750-labeled anti-CD11B, PerCP
Cy5.5-labeled anti-mouse CD11C, Alexa-700-labeled anti-IA/IE
(MHCII), APC labeled F4/80 (Ebioscince, San Diego, CA), FITC
labeled Gr-1 (BD Pharmingen, San Diego, CA) and LIVE/
DEADH Fixable Blue fluorescent reactive dye (Invitrogen, Carls-
bad, CA). Mouse isotype IgG served as a negative control and only
live cells were analyzed. Staining for live cells was performed after
cell surface marker staining, cells were washed (PBS) and LIVE/
DEADH dye (1 ml) was added. Flow cytometry was performed with
a FACSAria (Becton Dickinson, Franklin Lanes, NJ), and FlowJo
software (Treestar Inc, Ashland, OR) was used to analyze results.
To ensure that all samples had adequate cell numbers for
monocyte characterization in both bronchoalveolar lavage and
lung, pooled samples from left lungs of 6 mice were used for each
experiment at each time point. Only live cells were evaluated and
defined as macrophages (MHCII
int, CD11C+) and further
subdivided as alveolar macrophages (MHCII
int, CD11C+,
CD11B2) and lung macrophages (MHCII
int, CD11C+,
CD11B+) [18]. In preliminary studies, the MHCII
int, CD11C+
cell population was predominantly F4/80+, whereas neutrophils
(F4/802, Gr-1
high) represented less than 3% of this population.
This analysis is based partially on the work of Tighe [17]. In
additional experiments, alveolar macrophages (MHCII
int,
CD11C+, CD11B2) and lung macrophages (MHCII
int,
CD11C+, CD11B+) from lungs 0 h and 24 h after LPAL were
sorted, cells were plated (as above, in vitro cells), and 18 h later,
supernatants were collected for MIP-2a protein determination
(ELISA; R&D Systems).
Proliferation
Monocyte proliferation was determined by fluorescent PCNA
and FACS analysis as previously described [23]. Briefly, cells from
left lungs were washed (PBS), stained (LIVE/DEADH and
antibodies to MHCII, CD11C, CD11B), fixed and permeabi-
lized using a commercially available kit (Ebioscience) for further
PCNA staining, and analyzed. Flow cytometry was performed as
described above.
Monocyte/macrophage depletion with clodronate
liposomes
Mice were treated with clodronate liposomes [24] 100 ml; i.p.)
or control PBS liposomes (100 ml; i.p.) 24 h before LPAL.
Preliminary studies demonstrated that this treatment resulted in
a 53% reduction in tissue macrophages 24 h after LPAL.
Consequently, additional liposome treatments (100 ml; i.p. and
40 ml intratracheal aspiration) were given 1, 5 and 9 days after
LPAL (long treatment) or in another series of mice, only 1 day
after LPAL (short treatment). Angiogenesis was determined 14
days after LPAL.
Monocyte Differentiation
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After mice were anesthetized and intubated, the extent of
neovascularization was determined by measuring systemic blood
flow to the left lung 14 days after LPAL using fluorescent
microspheres (Invitrogen, Eugene, OR). The carotid artery was
cannulated and 360,000 microspheres (10 mm) were infused. Mice
were sacrificed by exsanguination and the left lung was excised.
Microspheres lodged in the left lung were quantified after tissue
digestion and fluorescent dye extraction, and the number calcu-
lated from a standard curve. Data are presented as the percent
total microspheres delivered, ie, % cardiac output.
Statistical analysis
Data are presented as the means 6 standard errors. ANOVA
was used to analyze changes in the number of lavaged monocyte/
macrophages. Student’s t-test was used to compare macrophage
number 0 h vs 24 h, changes in blood flow and absolute che-
mokine release and the Newman-Keuls Multiple Comparison test
was used for evaluation of cell number after clodronate treatment.
Percent change data were analyzed using Wilcoxon Signed Rank
test. A p value,0.05 was accepted at statistically significant.
Results
In vivo inflammatory cell identification
The early time course of the increase in macrophage numbers
in bronchoalveolar fluid was confirmed in the present series.
Figure 1 shows the number of lavaged monocytes/macrophages in
mice immediately after LPAL (0 h) and early (4 h and 24 h) after
LPAL compared to mice undergoing sham surgery. As previously
shown [12], mice undergoing sham surgery showed no change in
the number of lavaged macrophages, however, a substantial
increase in the number of monocytes/macrophages was observed
4 h and 24 h after LPAL (n=3–5 mice/group; p,0.05 compared
to sham). These increases paralleled the total number of lavaged
cells (2.6- and 2-fold increase vs sham, 4 and 24 h after LPAL;
p,0.05). Recovered volumes did not differ among groups and
averaged 0.7 ml for all mice (,80% recovery). Since the 0 h
values did not differ from sham operated mice at any time point, in
subsequent experiments the 0 h samples served as controls.
In vitro macrophage responsiveness
To explore one mechanism by which lung macrophages
contribute to systemic angiogenesis, we compared the ability of
naı ¨ve CD11C+ cells to secrete MIP-2a when stimulated with
putative agonists generated by the ischemic lung. MIP-2a se-
cretion averaged 4916147 pg/ml in CD11C+ cells in vehicle-
treated control conditions. Figure 2 shows the percent changes of
MIP-2a secretion from vehicle when CD11C+ cells were exposed
to low molecular weight hyaluronan (LMW HA) and H2O2. LMW
HA and H2O2 were equally effective at eliciting a significant
increase in MIP-2a release compared to vehicle control treatment
in CD11C+ cells (p,0.05). The combined treatments did not
induce an additive effect.
Macrophage phenotype
To further evaluate in vivo differentiation and compartmental
changes in cell type, we examined changes in all macrophages
(MHCII
int, CD11C+), alveolar macrophages (MHCII
int,
CD11C+, CD11B2) and lung macrophages (MHCII
int,
CD11C+, CD11B+) [18], 24 h after LPAL compared to 0 h,
separately in dissociated lung and bronchoalveolar lavage fluid.
Figure 3A shows examples of dot plots of dissociated lung 0 h and
24 h after LPAL. An increase in MHCII
int, CD11C+ cells is
observed. These cells were predominantly F4/80+ and results
demonstrated an increase from 0 h to 24 h, in the number of cells
that were CD11B+. Actual number of cells was determined (n=4
experiments/time point). Figure 3B shows the cell numbers in
BAL, lung, and the total number of cells for all macrophages
(MHCII
int, CD11C+). Twenty-four h after LPAL, a significant
increase in macrophages was observed compared to the cell
number seen initially at 0 h (p,0.02). This change represented an
average 91% increase in cell number. Changes in phenotype were
more obvious when examining specifically lung macrophages
(MHCII
int, CD11C+, CD11B+) seen in Figure 3C. A significant
increase in total (average 280% increase; p,0.05) and lung
Figure 1. Average early changes in macrophage numbers in bronchoalveolar lavage fluid in sham operated mice and mice after
LPAL (n=3–5 mice/group). Total cell counts paralleled the changes in macrophage number (* indicates p,0.05 sham vs LPAL).
doi:10.1371/journal.pone.0026716.g001
Monocyte Differentiation
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and a trend toward a change was observed in lung macrophages in
BAL (average 110% increase; p=0.06). Surprisingly, no changes
were seen in populations of alveolar macrophages (MHCII
int,
CD11C+, CD11B2) from BAL, lung or total number (Figure 3D).
When the two macrophage subgroups were analyzed for proli-
ferative capacity, there were no differences in mean PCNA fluore-
scence between lung macrophages and alveolar macrophages in
lung homogenate samples immediately after LPAL (0 h; Figure 4).
Although both showed slight increases in proliferation 24 h after
LPAL, these changes did not reach statistical significance.
In separate experiments, sorted lung macrophages (MHCII
int,
CD11C+, CD11B+) and alveolar macrophages (MHCII
int,
CD11C+, CD11B2) obtained from naı ¨ve lungs or lungs after
LPAL were studied after 18 h in culture. Supernatants evaluated
for MIP-2a showed spontaneous release of the CXC chemokine
only in mature lung macrophages from both naı ¨ve and LPAL
lungs (p,0.0001, n=12 lungs, Figure 5).
Angiogenesis assessment after monocyte/macrophage
depletion
The overall importance of cells of monocytic lineage to the
process of angiogenesis was assessed after treatment of mice with
clodronate liposomes. A long treatment before and throughout the
14 day period after LPAL with clodronate liposomes (n=6)
resulted in a 41% decrease in blood flow to the left lung compared
to treatment with PBS liposomes (n=9; p,0.05). Interestingly, 2
clodronate treatments (short treatment), only 24 h before and 24 h
after LPAL resulted in a similar average 44% decrement in
angiogenesis as assessed by neovascular perfusion (n=6) and this
value was not different from the results of the long multiple
treatment course. Consequently, the results of the two different
treatment schedules were combined and the results shown in
Figure 6 with individual data points representing individual mice
(red symbols: short treatment, black symbols: long treatment).
Blood flow to the left lung averaged 2.660.2% in PBS liposome
treated mice (n=13), a value similar to what has been seen
previously in wild type, untreated mice after LPAL [12]. Treat-
ment with clodronate liposomes (n=12 mice) resulted in an
average blood flow of 1.560.3%, which was significantly different
from vehicle-treated controls (p=0.006). These results suggest the
essential nature of monocyte- derived cells for systemic neovascu-
larization of the lung.
An additional series of mice was studied to confirm the changes
in macrophage subtype in mice treated with clodronate liposomes
(short treatment) and PBS vehicle controls. Because cells from
BAL constituted a small fraction of the total number of cells
(Figure 3B–3D), we extracted cells from dissociated left lungs
without bronchoalveolar lavage. The effects of treatment were
assessed 24 h and 5 d after LPAL and results are presented in
Figure 7 (cell #/10,000 live cells). Over the 4 groups studied (24 h
and 5 d, PBS vehicle liposomes and clodronate liposomes) there
were significant changes in all macrophages (p=0.005), mature
lung macrophages (p=0.008), and alveolar macrophages
(p,0.0001). Clodronate treatment (n=9 mice) resulted in a
significant decrease in the total number of macrophages by 24 h
compared to PBS liposome treatment (n=12 mice; p,0.05).
However, by 5 d after LPAL in both vehicle (n=4 mice) and
clodronate-treated mice (n=6 mice), the number of all macro-
phages within the lung was not statistically different from the 24 h
vehicle level. Mature lung macrophages were significantly reduced
in all groups compared to 24 h vehicle control level (p,0.05). The
number of alveolar macrophages was not significantly altered by
clodronate treatment 24 h after LPAL, however increased in both
vehicle and clodronate groups by 5 d (p,0.05).
Discussion
Macrophages have long been implicated as central participants
in the process of angiogenesis [25,26]. Both as a source of
endothelial cell growth factors [14], as well as matrix metallopro-
teinases essential to the invasion of new vessels [27], macrophages
have been shown to be abundant at the sites of neovascularization
and critical to the process. Previous work from our laboratory
showed a significant positive correlation between the number of
macrophages in the bronchoalveolar lavage fluid of the left lung
after complete pulmonary ischemia and the extent of systemic
angiogenesis [12]. Furthermore, macrophage-derived growth
factors, the CXC chemokines, are upregulated in the ischemic
lung [9] and are essential to the process of neovascularization
[10,11]. In the present study, we sought to better characterize the
trapped monocytes/macrophages in the lung early after the onset
of pulmonary ischemia. Although, previous studies have shown
monocyte differentiation in lung injury models and the recruit-
ment of specific macrophage subtypes, our model offered an
opportunity to study changes in monocyte phenotype in a closed,
in vivo environment where no new cells could be recruited until 5–
7 days after LPAL when new vessels were formed. We hypo-
thesized that monocytes both differentiate and proliferate in
response to sustained pulmonary ischemia and contribute to lung
remodeling through subsequent systemic angiogenesis. Our
experimental results demonstrate an increase in the number of
mature lung macrophages early after the onset of ischemia and
suggest an essential nature of these cells for angiogenesis.
In the present study, we first confirmed our previous obser-
vations demonstrating a significant increase in the number of
monocytes/macrophages that could be washed from airspaces of
Figure 2. Changes in MIP-2a secretion in isolated CD11C+
macrophages exposed to low molecular weight hyaluronan
(LMW HA) and H2O2. LMW HA and H2O2 were equally effective at
eliciting a significant increase in MIP-2a release compared to vehicle
control treatment in CD11C+ cells (p,0.05). The combined treatments
did not induce an additive effect.
doi:10.1371/journal.pone.0026716.g002
Monocyte Differentiation
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going sham surgery. At these early time points after the onset of
complete left lung ischemia, the source of the increase in cells in
the alveolar compartment could be only from within the lung
(interstitium, vasculature and/or proliferation). This is because the
mouse has no intrathoracic bronchial vasculature and a new
systemic angiogenic bed is not formed until 5 days after LPAL [7].
The increase in macrophage number was comparable to what was
previously reported [12].
Our next experiment confirmed that lung macrophages could
contribute to growth factor release in this model. Since we have
shown that CXC chemokines are essential to the process of
neovascularization [10,11], we sought to first confirm that ma-
crophages are a relevant source of these growth factors. We
challenged CD11C+ cells with hyaluronan fragments and H2O2,
since we have shown previously that ROS initiate the cascade
of events leading to systemic angiogenesis of the lung [8] and
hyaluronan fragmentation also contributes to neovascularization
[20]. We showed that these ischemia-induced agonists caused a
significant increase in the secretion of the MIP-2a, one of the
CXC chemokines, from CD11C+ cells. Others have shown these
agonists to elicit the release of several additional cytokines [19].
Based on this in vitro study, we speculate that the increase in
macrophages within the lung during ischemia, contributes to the
chemokine burden within the left lung shown previously for this
model and important for angiogenesis [9,10,11].
We subsequently questioned whether the increase in lavaged
macrophages observed originally, was due only to a movement of
macrophages into the alveolar compartment or whether the
increase reflected proliferation or differentiation in the lung.
Consequently, the 24 h time point was selected for a more com-
plete characterization of surface marker expression of monocytes/
macrophages in alveolar versus lung compartments and their total.
When evaluating all live macrophages using flow cytometry, we
Figure 3. Changes in macrophage numbers in dissociated left lung tissues after LPAL. 3A: Dot plots of dissociated lung 0 h and 24 h after
LPAL. The selected region of IA/IE (MHCII)
int, CD11C+ cells (1.13% of all live cells) increased 24 h after LPAL. As shown in the lower plots, these cells
were F4/80+, and CD11B+ cells increased 24 h after LPAL to 15.5%. 3B: Change in cell numbers of all macrophages (MHCII
int, CD11C+) in BAL
(bronchoalveolar lavage), dissociated lung, and their sum total, 0 h and 24 h after LPAL (n=4 experiments/group; * indicates p,0.02). 3C: Mature
lung macrophages (MHCII
int, CD11C+, CD11B+; * indicates p,0.05). 3D: Alveolar macrophages (MHCII
int, CD11C+, CD11B2).
doi:10.1371/journal.pone.0026716.g003
Monocyte Differentiation
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e26716saw significant increases only in samples of dissociated lung tissue
(Figure 3A). We can only suggest that the reason we did not see a
change in BAL cell numbers was related to more rigid criteria used
to identify this distinct population of macrophages based on
specific surface markers as well as the potential differences due to
processing cells for the two different evaluations. Furthermore, the
increase in macrophages in the lung compartment was due entirely
to the increase in mature lung macrophages expressing MHCII
int,
CD11C+, CD11B+ (Figure 3B) and not to changes in alveolar
macrophages (MHCII
int, CD11C+, CD11B2; Figure 3C). We
apply the nomenclature used by Landsman and colleagues who
showed that, based on surface marker expression, monocytes
normally differentiate within the lung from an immature state to
mature lung macrophages and finally to alveolar macrophages
[18]. Because the left lung in this model excludes peripheral blood
macrophages and no additional cells can be newly recruited to the
lung within the first 24 h after LPAL, this classification is ap-
propriate. Furthermore, no differences were seen in the prolifer-
ation between these two cell types (Figure 4). Thus, we conclude
from this phenotyping experiment, that there was differentiation of
immature monocytes in the lung to a more mature state
(MHCII
int, CD11C+, CD11B+) due to stimuli related to the
ischemic stress. This was somewhat reflected in the BAL which
showed a trend toward increased lung macrophages 24 h after
LPAL (p=0.06).
On further examination of the two macrophage subpopulations,
it was the mature lung macrophages (MHCII
int, CD11C+,
CD11B+) and not alveolar macrophages that, after sorting and
culturing in vitro, spontaneously released the CXC chemokine
MIP-2a (Figure 5). The flow cytometric analysis used in the
present study was partially modeled after the work of Tighe and
colleagues [17]. Interestingly, these investigators demonstrated
that the macrophage subpopulation that they termed exudative
macrophages (MHCII
int, CD11C+, CD11B+) were recruited to
the lung after bleomycin injury. Furthermore, it was this group of
cells that when stimulated in vitro with LPS and hyaluronan
fragments, produced MIP-2a. Despite the inability to recruit
circulating inflammatory cells in the LPAL injury model, it
appears that these cell populations may be the same and may be
activated by similar stimuli.
No changes in proliferation were observed in macrophage
subpopulations 24 h after LPAL. Our laboratory previously
reported an increase in the PCNA positive cells in the lung paren-
chyma after LPAL by immunohistochemistry [13]. However, this
Figure 4. No differences were seen in mean PCNA fluorescence
between lung macrophages and alveolar macrophages in lung
homogenate samples immediately after LPAL (0 h). Although
both subpopulations showed slight increases in proliferation 24 h after
LPAL, these changes did not reach statistical significance.
doi:10.1371/journal.pone.0026716.g004
Figure 6. Change in angiogenic blood flow to the left lung 14
days after LPAL in vehicle control mice compared to mice
treated with clodronate liposomes (each symbol represents
one mouse; red symbols=short treatment, black symbols=-
long treatment). Mice treated with PBS-liposomes showed a typical
systemic blood flow to the left lung compared with previously
published values [3]. Mice treated with clodronate liposomes, known
to reduce the number of monocytic cells, showed a substantial
reduction in systemic perfusion (* indicates p,0.006).
doi:10.1371/journal.pone.0026716.g006
Figure 5. Sorted mature lung macrophages (MHCII
int, CD11C+,
CD11B+) and alveolar macrophages (MHCII
int,C D 1 1 C +,
CD11B2) obtained from naı ¨ve lungs or lungs after LPAL were
studied after 18 h in culture. Supernatants evaluated for MIP-2a
showed spontaneous release only in mature lung macrophages
(* indicates p,0.0001, n=12 lungs).
doi:10.1371/journal.pone.0026716.g005
Monocyte Differentiation
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phages as well as alveolar type II cells and bronchial epithelial
cells. The present work is consistent with prior results.
The importance of mature lung macrophages to the process of
angiogenesis was suggested by treating mice with clodronate
liposomes which deplete cells of monocytic lineage [24]. We
made functional measurements of angiogenesis determined by
systemic perfusion to the left lung 14 d after LPAL. Treatment
before and throughout the 14 d period after LPAL with
clodronate liposomes (long treatment) resulted in a 41% decrease
in blood flow to the left lung compared to treatment with PBS
liposomes. Blood flow to the left lung in PBS liposome treated
mice resulted in similar values to what has been seen previously
in wild type, untreated mice after LPAL [12]. Interestingly, in
another group of mice treated with clodronate liposomes, only
24 h before and 24 h after LPAL (short treatment), showed a
similar 44% decrement in angiogenesis. In additional mice, we
confirmed the change in number and macrophage phenotype
in mice treated with clodronate (short treatment; Figure 7).
Clodronate liposome treatment resulted in a significant decrease
in the total number of macrophages by 24 h compared with PBS
liposome treatment. However, by 5 d after LPAL in both vehicle
and clodronate-treated mice, the number of all macrophages
within the lung was not different from the 24 h vehicle level.
Mature lung macrophages were reduced 24 h after LPAL in the
clodronate treated mice and remained decreased at 5 d LPAL in
both vehicle and clodronate treated mice. The results of
macrophage phenotype determination (Figure 7) and angiogen-
esis with long and short clodronate treatments (Figure 6)
highlight the importance of lung macrophages early in the
process of neovascularization. The longer and shorter treatments
resulted in similar effects on angiogenesis measured 14 d after
LPAL yet the shorter clodronate treatment was no longer
effective at keeping the level of all macrophages suppressed after
5 d LPAL. Additionally, mature lung macrophages, the primary
chemokine-producing cells (Figure 2) were significantly de-
creased after 5 d LPAL yet did not differ between vehicle and
clodronate groups. These results further suggest the importance
of mature lung macrophages as chemokine growth factor
producing cells very early after LPAL (,5d ) .T h i si n t e r p r e t -
ation is consistent with our previous work that demonstrated
chemokine expression and protein is an early event (0–3 days;
[9]. Although clodronate may have had a direct effect on blood
vessel formation, we believe these results show a strong asso-
ciation of the early differentiation of monocytes to mature lung
macrophages with the process that leads to systemic neovascu-
larization of the lung.
Several recent review articles highlight the heterogeneity and
plasticity of cells of monocyte lineage [28,29]. In the present
study, we have taken advantage of the mouse lung which lacks
an intrathoracic bronchial vasculature and observed changes in
macrophage phenotype after LPAL that underscore monocyte
plasticity. In summary, our results demonstrate that ischemic
stress within the lung contributes to the differentiation of
immature monocytes to mature lung macrophages within the
first 24 h after LPAL. Lung macrophages but not alveolar
macrophages increase in number early after ischemia and
secrete the proangiogenic chemokine MIP-2a. Overall, an
increase in the number of lung macrophages appears critical for
the process of neovascularization in the lung, since clodronate
treatment decreased their number and attenuated functional
angiogenesis.
Figure 7. Changes in macrophage subtype in mice treated with clodronate liposomes. The effects of the short liposome treatment were
assessed 24 h and 5 d after LPAL (cell #/10,000 live cells). Over the 4 groups studied (24 h and 5 d, PBS vehicle liposomes and clodronate liposomes)
there were significant changes in all macrophages (p=0.005), mature lung macrophages (p=0.008), and alveolar macrophages (p,0.0001).
Clodronate treatment (n=9 mice) resulted in a significant decrease in the total number of macrophages by 24 h compared with PBS liposome
treatment (n=12 mice). However, by 5 d after LPAL in both vehicle (n=4 mice) and clodronate-treated mice (n=6 mice), the number of all
macrophages within the lung was not statistically different from the 24 h vehicle level. Mature lung macrophages were significantly reduced in all
groups compared to 24 h vehicle control level. The number of alveolar macrophages was not significantly altered by clodronate treatment 24 h after
LPAL, however increased in both vehicle and clodronate groups by 5 d. * indicates p,0.05 compared to 24 h vehicle.
doi:10.1371/journal.pone.0026716.g007
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